BIOGEN PHARMACHEM INDUSTRIES L
Who owns it
The register is entirely public — other public holders form the largest block at 73.4%.
Each block is that holder-kind’s share of the company; counts are shareholder accounts, so one holder may hold several. As filed.
The public holds 100% as of Jun 2026. No promoter has ever appeared.
The first and latest quarters on record. Moves under 0.25pp show grey.
8 holders name themselves in this filing — promoters, institutions and public holders.
Plus 1 further holders below 0.1%, 0.01% between them.
Ownership shown is promoter and public holding split by category, the named holders, and promoter pledge.
How it trades
Loading trading data…
Splits, bonuses and rights
- 15 May 2026
1 free share for every 6 held — every 6 shares became 7. The price divides by the same factor, so a chart falling about 14% that day is that arithmetic, not a loss.
Shown from Aug 2024, as far back as we can certify the record complete; earlier actions are not listed. Scheduled dividends are listed ahead of their ex-date, and past dividend ex-dates from the same window when on record — a stock with none shown either paid none in that window or predates our records; never read the absence as BIOGEN PHARMACHEM INDUSTRIES L having paid none.
Fundamentals and valuation — we hold neither. The government share of public holding — not broken out separately.
BIOGEN PHARMACHEM INDUSTRIES L — a factual record of what it disclosed to the exchange and how its shares have traded, never advice. Every figure is dated to its filing; absence is stated, never shown as zero.